These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37498533)

  • 1. Estimates of hepatitis B virus prevalence among general population and key risk groups in EU/EEA/UK countries: a systematic review.
    Bivegete S; McNaughton AL; Trickey A; Thornton Z; Scanlan B; Lim AG; Nerlander L; Fraser H; Walker JG; Hickman M; Vickerman P; Johnson H; Duffell E; Brooks-Pollock E; Christensen H
    Euro Surveill; 2023 Jul; 28(30):. PubMed ID: 37498533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study.
    Trickey A; Bivegete S; Duffell E; McNaughton AL; Nerlander L; Walker JG; Fraser H; Hickman M; Vickerman P; Brooks-Pollock E; Christensen H
    BMC Infect Dis; 2023 Jul; 23(1):457. PubMed ID: 37430220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
    BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review.
    Hofstraat SHI; Falla AM; Duffell EF; Hahné SJM; Amato-Gauci AJ; Veldhuijzen IK; Tavoschi L
    Epidemiol Infect; 2017 Oct; 145(14):2873-2885. PubMed ID: 28891457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C prevalence and incidence in key population groups with multiple risk factors in the EU/EEA: a systematic review.
    Mason LM; Duffell E; Veldhuijzen IK; Petriti U; Bunge EM; Tavoschi L
    Euro Surveill; 2019 Jul; 24(30):. PubMed ID: 31362808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.
    Falla AM; Ahmad AA; Duffell E; Noori T; Veldhuijzen IK
    BMC Infect Dis; 2018 Jan; 18(1):42. PubMed ID: 29338702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis C infection among the general population and high-risk groups in the EU/EEA: a systematic review update.
    Han R; Zhou J; François C; Toumi M
    BMC Infect Dis; 2019 Jul; 19(1):655. PubMed ID: 31337339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review.
    Myran DT; Morton R; Biggs BA; Veldhuijzen I; Castelli F; Tran A; Staub LP; Agbata E; Rahman P; Pareek M; Noori T; Pottie K
    Int J Environ Res Public Health; 2018 Sep; 15(9):. PubMed ID: 30200406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus infection in EU/EEA and United Kingdom prisons: a descriptive analysis.
    Nakitanda AO; Montanari L; Tavoschi L; Mozalevskis A; Duffell E
    Epidemiol Infect; 2021 Jan; 149():e59. PubMed ID: 33487201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021.
    Singh J; Stoitsova S; Zakrzewska K; Henszel L; Rosińska M; Duffell E
    BMC Public Health; 2022 Dec; 22(1):2260. PubMed ID: 36463162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014.
    Miglietta A; Quinten C; Lopalco PL; Duffell E
    Euro Surveill; 2018 Feb; 23(6):. PubMed ID: 29439751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and C among healthcare workers and patient groups at increased risk of iatrogenic transmission in the European Union/European Economic Area.
    Tavoschi L; Mason L; Petriti U; Bunge E; Veldhuijzen I; Duffell E
    J Hosp Infect; 2019 Aug; 102(4):359-368. PubMed ID: 30885816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis.
    Im YR; Jagdish R; Leith D; Kim JU; Yoshida K; Majid A; Ge Y; Ndow G; Shimakawa Y; Lemoine M
    Lancet Gastroenterol Hepatol; 2022 Oct; 7(10):932-942. PubMed ID: 35961359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review.
    Mason LMK; Veldhuijzen IK; Duffell E; van Ahee A; Bunge EM; Amato-Gauci AJ; Tavoschi L
    J Viral Hepat; 2019 Dec; 26(12):1431-1453. PubMed ID: 31332919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
    Hahné SJ; Veldhuijzen IK; Wiessing L; Lim TA; Salminen M; Laar Mv
    BMC Infect Dis; 2013 Apr; 13():181. PubMed ID: 23597411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of barriers and facilitators for hepatitis B and C screening among migrants in the EU/EEA region.
    Moonen CPB; den Heijer CDJ; Dukers-Muijrers NHTM; van Dreumel R; Steins SCJ; Hoebe CJPA
    Front Public Health; 2023; 11():1118227. PubMed ID: 36875381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of chronic hepatitis B and risk factor assessment in Turkish migrants, Middle Limburg, Belgium.
    Koc ÖM; Kremer C; Hens N; Bielen R; Busschots D; Van Damme P; Robaeys G
    PLoS One; 2020; 15(7):e0234740. PubMed ID: 32716949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care screening, prevalence, and risk factors for hepatitis B infection among 3,728 mainly undocumented migrants from non-EU countries in northern Italy.
    El-Hamad I; Pezzoli MC; Chiari E; Scarcella C; Vassallo F; Puoti M; Ciccaglione A; Ciccozzi M; Scalzini A; Castelli F;
    J Travel Med; 2015; 22(2):78-86. PubMed ID: 25424439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and C surveillance and screening programmes in the non-EU/EEA Member States of the WHO European Region: survey findings from 10 countries, 2012.
    Mozalevskis A; Eramova I; Safreed-Harmon K; Lazarus JV
    Euro Surveill; 2016 Jun; 21(22):. PubMed ID: 27277421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.